NU62PS924853
Cooperative Agreement
Overview
Grant Description
Virgin Islands high-impact HIV surveillance programs - The United States Virgin Islands (USVI) is an archipelago consisting of four islands with a population of 87,146.
The USVI faces unique challenges in addressing the HIV epidemic due to its geographical location, cultural diversity, and limited resources.
Efforts have been made to combat HIV, including the implementation of increased testing and awareness campaigns.
Currently, there are approximately 825 individuals living with HIV in the USVI, with only 0.946% aware of their status.
Between 2018 and 2022, there were 62 new HIV diagnoses, and an alarming 25% of individuals were already at an advanced stage of the disease at the time of diagnosis.
Males and individuals over 55 years old bear a higher burden of HIV infection, and 59.6% of new diagnoses occur among Black or African American individuals.
Access to HIV medical care is crucial, with only 25.3% of individuals receiving care and 40.2% achieving viral suppression by 2022.
Strengthening healthcare systems and expanding access to care are vital for improving outcomes.
To address the HIV epidemic, the United States Virgin Islands (USVI) is implementing a comprehensive multi-sectoral approach aligned with the goals of the National HIV/AIDS Strategy (NHAS).
The project focuses on several key strategies to combat HIV, including enhancing surveillance systems to gather accurate data, increasing HIV testing and awareness, improving access to medical care and treatment, targeting prevention interventions for key populations, fostering community engagement, and coordinating efforts among stakeholders.
The aim is to overcome challenges such as limited resources, stigma, and socioeconomic factors, and to make significant progress in HIV prevention, testing, treatment, and care in the USVI.
The implementation of these strategies is expected to yield short-term and intermediate outcomes.
In the short term, the project aims to achieve increased routine HIV screening, improved availability of testing services, identification of new HIV cases and individuals not in care, and integrated screening approaches.
These efforts are intended to increase knowledge of HIV status, reduce late diagnoses, and improve linkage to care.
Also, focusing on rapid and effective treatment for diagnosed individuals.
The short-term outcomes of this strategy include rapid linkage to care, provision of HIV partner services, engagement in prevention and treatment services, early initiation of antiretroviral therapy (ART), and the provision of supportive services.
The intermediate outcomes involve increased receipt of medical care and achieving viral suppression, which is essential for long-term health and prevention of transmission.
We are aiming to prevent new HIV transmissions.
The short-term outcomes include increased linkage to pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) services, improved availability of harm reduction approaches, awareness-raising initiatives, enhanced perinatal HIV surveillance, and improved perinatal services.
The intermediate outcomes involve increased utilization of PrEP and PEP, higher adoption of harm reduction strategies, and reduced perinatal HIV infections.
Creating strategies to respond to HIV clusters and outbreaks.
The short-term outcomes include improved cluster data and response activities.
The intermediate outcomes involve reduced transmission, improved care and prevention, addressing disparities, enhanced coordination among stakeholders, contact tracing, implementation of evidence-based interventions, and strengthening of local capacity to respond effectively to HIV clusters and outbreaks.
Conducts HIV surveillance to gather accurate and actionable data.
The short-term outcomes include improved completeness, timeliness, accuracy, monitoring of HIV trends and disparities, and enhanced data security.
The intermediate outcomes involve using surveillance data to identify affected populations and disparities, improving data exchange between relevant entities.
The USVI faces unique challenges in addressing the HIV epidemic due to its geographical location, cultural diversity, and limited resources.
Efforts have been made to combat HIV, including the implementation of increased testing and awareness campaigns.
Currently, there are approximately 825 individuals living with HIV in the USVI, with only 0.946% aware of their status.
Between 2018 and 2022, there were 62 new HIV diagnoses, and an alarming 25% of individuals were already at an advanced stage of the disease at the time of diagnosis.
Males and individuals over 55 years old bear a higher burden of HIV infection, and 59.6% of new diagnoses occur among Black or African American individuals.
Access to HIV medical care is crucial, with only 25.3% of individuals receiving care and 40.2% achieving viral suppression by 2022.
Strengthening healthcare systems and expanding access to care are vital for improving outcomes.
To address the HIV epidemic, the United States Virgin Islands (USVI) is implementing a comprehensive multi-sectoral approach aligned with the goals of the National HIV/AIDS Strategy (NHAS).
The project focuses on several key strategies to combat HIV, including enhancing surveillance systems to gather accurate data, increasing HIV testing and awareness, improving access to medical care and treatment, targeting prevention interventions for key populations, fostering community engagement, and coordinating efforts among stakeholders.
The aim is to overcome challenges such as limited resources, stigma, and socioeconomic factors, and to make significant progress in HIV prevention, testing, treatment, and care in the USVI.
The implementation of these strategies is expected to yield short-term and intermediate outcomes.
In the short term, the project aims to achieve increased routine HIV screening, improved availability of testing services, identification of new HIV cases and individuals not in care, and integrated screening approaches.
These efforts are intended to increase knowledge of HIV status, reduce late diagnoses, and improve linkage to care.
Also, focusing on rapid and effective treatment for diagnosed individuals.
The short-term outcomes of this strategy include rapid linkage to care, provision of HIV partner services, engagement in prevention and treatment services, early initiation of antiretroviral therapy (ART), and the provision of supportive services.
The intermediate outcomes involve increased receipt of medical care and achieving viral suppression, which is essential for long-term health and prevention of transmission.
We are aiming to prevent new HIV transmissions.
The short-term outcomes include increased linkage to pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) services, improved availability of harm reduction approaches, awareness-raising initiatives, enhanced perinatal HIV surveillance, and improved perinatal services.
The intermediate outcomes involve increased utilization of PrEP and PEP, higher adoption of harm reduction strategies, and reduced perinatal HIV infections.
Creating strategies to respond to HIV clusters and outbreaks.
The short-term outcomes include improved cluster data and response activities.
The intermediate outcomes involve reduced transmission, improved care and prevention, addressing disparities, enhanced coordination among stakeholders, contact tracing, implementation of evidence-based interventions, and strengthening of local capacity to respond effectively to HIV clusters and outbreaks.
Conducts HIV surveillance to gather accurate and actionable data.
The short-term outcomes include improved completeness, timeliness, accuracy, monitoring of HIV trends and disparities, and enhanced data security.
The intermediate outcomes involve using surveillance data to identify affected populations and disparities, improving data exchange between relevant entities.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Virgin Islands
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 258% from $1,006,295 to $3,606,707.
Virgin Islands Department Of Health was awarded
US Virgin Islands HIV Surveillance & Prevention Grant
Cooperative Agreement NU62PS924853
worth $3,606,707
from National Center for HIV, Viral Hepatitis, STD, and TB Prevention in August 2024 with work to be completed primarily in Virgin Islands United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.939 HIV Prevention Activities Non-Governmental Organization Based.
The Cooperative Agreement was awarded through grant opportunity High-Impact HIV Prevention and Surveillance Programs for Health Departments.
Status
(Ongoing)
Last Modified 6/22/26
Period of Performance
8/1/24
Start Date
5/31/29
End Date
Funding Split
$3.6M
Federal Obligation
$0.0
Non-Federal Obligation
$3.6M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU62PS924853
Additional Detail
Award ID FAIN
NU62PS924853
SAI Number
NU62PS924853-675332090
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVJ0 CDC NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TUBERCULOSIS PREVENTION
Awardee UEI
HC9KX4GNNPK6
Awardee CAGE
346X8
Performance District
VI-98
Modified: 6/22/26